These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15251380)

  • 1. Metaanalysis of statins and survival in de novo cardiac transplantation.
    Mehra MR; Raval NY
    Transplant Proc; 2004 Jun; 36(5):1539-41. PubMed ID: 15251380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
    Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
    J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
    Kobashigawa JA; Moriguchi JD; Laks H; Wener L; Hage A; Hamilton MA; Cogert G; Marquez A; Vassilakis ME; Patel J; Yeatman L
    J Heart Lung Transplant; 2005 Nov; 24(11):1736-40. PubMed ID: 16297773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z; Rahme E; Pilote L
    Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-related adverse events: a meta-analysis.
    Silva MA; Swanson AC; Gandhi PJ; Tataronis GR
    Clin Ther; 2006 Jan; 28(1):26-35. PubMed ID: 16490577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperlipidemia in cardiac transplant recipients.
    Bilchick KC; Henrikson CA; Skojec D; Kasper EK; Blumenthal RS
    Am Heart J; 2004 Aug; 148(2):200-10. PubMed ID: 15308989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients.
    Wallace CK; Stetson SJ; Küçüker SA; Becker KA; Farmer JA; McRee SC; Koerner MM; Noon GP; Torre-Amione G
    J Heart Lung Transplant; 2005 Jan; 24(1):46-51. PubMed ID: 15653378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
    Sadoni S; Kaczmarek I; Delgado O; Schmöckel M; Reichart B; Meiser B
    Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry.
    Wu AH; Ballantyne CM; Short BC; Torre-Amione G; Young JB; Ventura HO; Eisen HJ; Radovancevic B; Rayburn BK; Lake KD; Yancy CW; Taylor DO; Mehra MR; Kubo SH; Fishbein DP; Zhao XQ; O'Brien KD
    Am J Cardiol; 2005 Feb; 95(3):367-72. PubMed ID: 15670546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice.
    Grigioni F; Carigi S; Potena L; Fabbri F; Russo A; Musuraca AC; Coccolo F; Magnani G; Ortolani P; Leone O; Arpesella G; Magelli C; Branzi A
    Transplant Proc; 2006 Jun; 38(5):1507-10. PubMed ID: 16797344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of simvastatin therapy after heart transplantation an 11-year prospective evaluation.
    Wenke K; Meiser B; Thiery J; Reichart B
    Herz; 2005 Aug; 30(5):431-2. PubMed ID: 16132246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients.
    O'Regan C; Wu P; Arora P; Perri D; Mills EJ
    Am J Med; 2008 Jan; 121(1):24-33. PubMed ID: 18187070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation.
    Mahle WT; Vincent RN; Berg AM; Kanter KR
    J Heart Lung Transplant; 2005 Jan; 24(1):63-6. PubMed ID: 15653381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysis.
    Messerli FH; Pinto L; Tang SS; Thakker KM; Cappelleri JC; Sichrovsky T; Dubois RW
    Am J Cardiol; 2008 Feb; 101(3):319-25. PubMed ID: 18237593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival with statins, angiotensin receptor blockers, and steroid weaning after heart transplantation.
    Lubitz SA; Baran DA; Alwarshetty MM; Zucker MJ; Arroyo LH; Chan M; Courtney MC; Correa R; Spielvogel D; Lansman SL; Gass AL
    Transplant Proc; 2006 Jun; 38(5):1501-6. PubMed ID: 16797343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
    Fellström B; Abedini S; Holdaas H; Jardine AG; Staffler B; Gimpelewicz C;
    Clin Transplant; 2006; 20(6):732-9. PubMed ID: 17100723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin-associated QTc interval shortening as prognostic indicator in heart transplant recipients.
    Vrtovec B; Stojanovic I; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Radovancevic B
    J Heart Lung Transplant; 2006 Feb; 25(2):234-6. PubMed ID: 16446226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.